Schilke Tobin

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
19-Mar-24 6:44 PM
View: 
Revance Therapeutics, Inc. (RVNC) 18-Mar-24Sale 9,361$5.04$47,203.80(5%)
202.03K to 192.67K
19-Mar-24 6:44 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Mar-24Payment of Exercise 3,822$5.30$20,275.70(2%)
205.85K to 202.03K
04-Mar-24 4:44 PM
View: 
Revance Therapeutics, Inc. (RVNC) 29-Feb-24Grant 17,447----9%
188.4K to 205.85K
02-Feb-24 4:46 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Jan-24Grant 96,667----105%
91.73K to 188.4K
03-Jan-24 4:48 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-23Grant 434$7.47$3,241.98< 1%
91.3K to 91.73K
15-Aug-23 4:16 PM
View: 
Revance Therapeutics, Inc. (RVNC) 11-Aug-23Grant 22,620----28%
79.9K to 102.52K
15-Aug-23 4:16 PM
View: 
Revance Therapeutics, Inc. (RVNC) 11-Aug-23Payment of Exercise 11,215$18.91$212,076.00(11%)
102.52K to 91.3K
05-Jul-23 10:00 PM
View: 
Revance Therapeutics, Inc. (RVNC) 03-Jul-23Private Sale (Planned) 1,701$25.04$42,593.00(2%)
81.6K to 79.9K
05-Jul-23 10:00 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Jun-23Grant 769$15.61$12,001.00< 1%
80.83K to 81.6K
(1%)
05-Jun-23 6:06 PM
View: 
Revance Therapeutics, Inc. (RVNC) 02-Jun-23Sale (Planned) 500$31.00$15,500.00(< 1%)
81.33K to 80.83K
05-Jun-23 6:06 PM
View: 
Revance Therapeutics, Inc. (RVNC) 01-Jun-23Private Sale (Planned) 2,701$30.57$82,569.60(3%)
84.03K to 81.33K
16-May-23 8:29 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-May-23Sale 21,401$34.55$739,338.00(20%)
105.43K to 84.03K
02-May-23 4:01 PM
View: 
Revance Therapeutics, Inc. (RVNC) 01-May-23Private Sale (Planned) 3,201$31.70$101,472.00(5%)
66.28K to 63.08K
04-Apr-23 4:24 PM
View: 
Revance Therapeutics, Inc. (RVNC) 03-Apr-23Private Sale (Planned) 3,201$32.15$102,912.00(5%)
69.48K to 66.28K
17-Mar-23 3:21 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Mar-23Payment of Exercise 3,739$30.65$114,600.00(5%)
73.22K to 69.48K
09-Mar-23 10:00 PM
View: 
Revance Therapeutics, Inc. (RVNC) 09-Mar-23Sale 18,517$31.59$584,884.00(20%)
91.74K to 73.22K
02-Mar-23 9:25 PM
View: 
Revance Therapeutics, Inc. (RVNC) 01-Mar-23Private Sale (Planned) 3,201$33.50$107,234.00(6%)
52.59K to 49.39K
16-Feb-23 8:28 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Feb-23Payment of Exercise 2,085$33.21$69,242.90(4%)
54.68K to 52.59K
02-Feb-23 9:38 PM
View: 
Revance Therapeutics, Inc. (RVNC) 01-Feb-23Private Sale (Planned) 3,201$34.60$110,755.00(6%)
57.88K to 54.68K
23-Jan-23 5:35 PM
View: 
Revance Therapeutics, Inc. (RVNC) 20-Jan-23Private Sale (Planned) 1,000$31.00$31,000.00(2%)
58.88K to 57.88K
10-Jan-23 8:06 PM
View: 
Revance Therapeutics, Inc. (RVNC) 09-Jan-23Private Sale (Planned) 3,701$27.16$100,525.00(6%)
62.58K to 58.88K
03-Jan-23 4:29 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-22Grant 645$12.18$7,856.421%
61.93K to 62.58K
16-Dec-22 4:12 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Dec-22Payment of Exercise 1,557$21.50$33,475.50(2%)
63.49K to 61.93K
09-Mar-23 10:00 PM
View: 
Revance Therapeutics, Inc. (RVNC) 22-Sep-22Grant 42,349----86%
49.39K to 91.74K
05-Jul-22 6:15 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Jun-22Grant 965$11.75$11,335.902%
62.52K to 63.49K
17-Mar-22 5:48 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Mar-22Payment of Exercise 2,607$15.79$41,164.50(4%)
65.13K to 62.52K
2%
17-Feb-22 8:49 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Feb-22Payment of Exercise 2,924$13.35$39,035.40(4%)
68.06K to 65.13K
16-May-23 8:29 PM
View: 
Revance Therapeutics, Inc. (RVNC) 02-Feb-22Grant 42,349----67%
63.08K to 105.43K
04-Jan-22 8:58 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-21Acquisition (other) 404$13.87$5,604.29< 1%
67.65K to 68.06K
17-Dec-21 5:31 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Dec-21Payment of Exercise 1,556$15.92$24,771.50(2%)
69.21K to 67.65K
(< 1%)
02-Jul-21 7:53 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Jun-21Acquisition (other) 446$24.09$10,743.70< 1%
68.76K to 69.21K
19-Feb-21 8:15 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Feb-21Payment of Exercise 2,657$28.97$76,973.30(4%)
71.42K to 68.76K
3%
04-Feb-21 9:15 PM
View: 
Revance Therapeutics, Inc. (RVNC) 02-Feb-21Grant 22,620----46%
48.8K to 71.42K
04-Jan-21 8:02 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-20Acquisition (other) 493$21.36$10,530.701%
48.31K to 48.8K
22-Dec-20 8:39 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Dec-20Payment of Exercise 1,556$26.75$41,623.00(3%)
49.86K to 48.31K
(3%)
02-Oct-20 8:32 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Sep-20Grant 15,750----40%
39.56K to 55.31K
02-Oct-20 8:32 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Sep-20Payment of Exercise 5,446$25.14$136,912.00(10%)
55.31K to 49.86K
(10%)
02-Jul-20 8:18 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Jun-20Acquisition (other) 763$13.80$10,526.002%
38.8K to 39.56K
19-Feb-20 8:21 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Feb-20Payment of Exercise 576$25.33$14,590.10(1%)
39.37K to 38.8K
(9%)
24-Jan-20 8:21 PM
View: 
Revance Therapeutics, Inc. (RVNC) 23-Jan-20Grant 16,500----72%
22.87K to 39.37K
03-Jan-20 6:42 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-19Acquisition (other) 504$10.82$5,453.282%
22.37K to 22.87K
1%
17-Dec-19 7:57 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Dec-19Payment of Exercise 1,556$15.99$24,880.40(7%)
23.92K to 22.37K
(73%)
02-Jul-19 9:16 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Jun-19Acquisition (other) 923$11.02$10,175.604%
23.0K to 23.92K
(< 1%)
25-Jan-19 9:00 PM
View: 
Revance Therapeutics, Inc. (RVNC) 24-Jan-19Grant 5,000----28%
18.0K to 23.0K
07-Nov-18 8:31 PM
View: 
Revance Therapeutics, Inc. (RVNC) 05-Nov-18Grant 18,000----100%
0 to 18.0K
28-Jun-18 4:20 PM
View: 
Achaogen, Inc. (AKAO) 26-Jun-18Grant 860----2%
47.19K to 48.05K
28-Jun-18 4:20 PM
View: 
Achaogen, Inc. (AKAO) 26-Jun-18Market Sale 298$9.59$2,857.82(< 1%)
48.05K to 47.75K
90%
13-Jun-18 5:03 PM
View: 
Achaogen, Inc. (AKAO) 11-Jun-18Market Sale 2,087$11.95$24,939.70(4%)
49.27K to 47.19K
92%
23-Feb-18 8:38 PM
View: 
Achaogen, Inc. (AKAO) 21-Feb-18Market Sale 1,108$10.67$11,822.40(3%)
41.29K to 40.19K
91%
15-May-18 6:33 PM
View: 
Achaogen, Inc. (AKAO) 08-Feb-18Grant 6,880----17%
40.19K to 47.06K